ShareHope Medicine Co., Ltd. (TPEX:8403)
23.05
-0.10 (-0.43%)
Mar 6, 2026, 1:30 PM CST
ShareHope Medicine Market Cap
ShareHope Medicine has a market cap or net worth of 3.17 billion as of March 6, 2026. Its market cap has decreased by -15.38% in one year.
Market Cap
3.17B
Enterprise Value
3.74B
Revenue
4.34B
Ranking
n/a
PE Ratio
18.04
Stock Price
23.05
Market Cap Chart
Since December 24, 2008, ShareHope Medicine's market cap has increased from 525.00M to 3.17B, an increase of 504.31%. That is a compound annual growth rate of 11.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.17B | -1.28% |
| Dec 31, 2025 | 3.21B | -15.31% |
| Dec 31, 2024 | 3.79B | -8.49% |
| Dec 29, 2023 | 4.15B | 2.20% |
| Dec 30, 2022 | 4.06B | 31.44% |
| Dec 30, 2021 | 3.09B | -18.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 255.73B |
| Caliway Biopharmaceuticals | 220.87B |
| Heron Neutron Medical | 76.84B |
| Lotus Pharmaceutical | 70.74B |
| Merdury Biopharmaceutical | 3.32B |
| LIWANLI Innovation | 3.30B |
| ICARES Medicus | 3.28B |
| WeLeader Biomedical | 3.23B |